ElastQ aids in the diagnosis of various liver conditions, including hepatitis B and C, liver cancer and cirrhosis.
The device uses shear wave elastography to assess soft liver tissue for stiffness — a sign of issues with the organ — without the need for a liver biopsy.
ElastQ offers a larger field of vision, color-coded quantitative assessment of the tissue stiffness, and real-tine feedback and intelligent analysis, according to a news release.
More articles on supply chain:
Bernie Sanders introduces drug importation bill to lower medicine costs: 5 takeaways
Drug spending rose faster under ACA plans than other health plans
FDA: Drug manufacturing at Pfizer’s Kansas plant is ‘out of control’
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
